| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918159 | Radiotherapy and Oncology | 2015 | 5 Pages |
Abstract
The published data are broadly consistent with a linear quadratic dose-response model. Dose-individualization in anal cancer should be further investigated in the context of clinical trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Rebecca Muirhead, Mike Partridge, Maria A. Hawkins,